Digestive System Carcinoma — Trials

Digestive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7,545 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,124
Recruiting: 1,216
Ph III recruiting: 129
Growth YoY: +12.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (885)

clinicaltrialsPublishedShowing 651–700 of 1,111 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05651022	Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors	active not recruiting	Phase 1 / Phase 2	120	Indaptus Therapeutics, IncINDUSTRY	1	Jan 13, 2026	clinicaltrials
NCT06312982	A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer	recruiting	Phase 2 / Phase 3	375	Beijing Friendship HospitalOTHER	1	Jan 13, 2026	clinicaltrials